Fisher on the NZX
This ranking weighs Revenue growth ×4, Analyst upside ×3, Buy % ×2, Gross margin ×2, and nothing else, across the 20 companies we track on the NZX. Fisher set no numeric limits at all, so no company here is ever flagged: his fifteen points are qualitative.
Ranked highest by Fisher on this market right now, which is not the same list as the one that clears the limits above:
- Summerset (SUM.NZ) · Healthcare · Revenue growth 15.9% · Analyst upside 60.1% · Buy % 80% · Gross margin 12%
- Ryman Healthcare (RYM.NZ) · Healthcare · Revenue growth 11.9% · Analyst upside 50.0% · Buy % 75% · Gross margin 9%
- SkyCity (SKC.NZ) · Consumer Cyclical · Revenue growth 0.7% · Analyst upside 50.7% · Buy % 100% · Gross margin 46%
- KMD Brands (KMD.NZ) · Consumer Cyclical · Revenue growth 7.3% · Analyst upside 30.7% · Buy % 25% · Gross margin 56%
- EBOS Group (EBO.NZ) · Healthcare · Revenue growth 7.1% · Analyst upside 45.2% · Buy % 71% · Gross margin 13%
From data as of 2026-09-11 01:00:55 UTC. Rebuilt every hour; the table above is live.